. may 16, 2018
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Cipriani-sister-of-Walberg-from-Campo?Guiberteau=120
. may 15, 2018
.
.
.
us opioid crisis hits indian pharma companies